EKF Diagnostics, the global in-vitro diagnostics company, announces that its Quo-Test ® HbA1c analyzer is successfully supporting improved medical management of patients with sight-threatening ...

New York, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Hemoglobin A1c Analyzer Market Research Report by Product, by Technology, by Type, by End User, by ...

EKF Diagnostics, the global in vitro diagnostics company, has announced the successful evaluation of its Quo-Lab® point-of-care HbA1c analyzer by the European Reference Laboratory for Glycohemoglobin.

Quo-Lab meets strict international quality targets – confirming it fit for purpose for diabetes testing The study aimed to evaluate the four POC HbA1c instruments according to Clinical and Laboratory ...

The market research report provides a comprehensive analysis of the Hemoglobin A1C Analyzer industry. The report examines the current state of the market, including its size, growth rate, and major ...

NEW YORK, July 4, 2019 /PRNewswire/ -- The increasing prevalence of diabetes remains a key factor fuelling HbA1c sales globally. Increasing geriatric population and the different advantages of HbA1c ...

Apart from factors driving the growth of the HbA1c analyzers market, there are few factors that are likely to restrain the growth of the HbA1c analyzer market. The poor availability of HbA1c analyzers ...